Noom's microdose program uses 0.1-0.6mg doses (up to 25% of standard maintenance) combined with behavioral coaching
In a recent article in the Journal of the American Medical Association, researchers describe what they found after purchasing products from some of these sites
Through these insights, it's suggested that effective patient communication and engagement in GLP-1 therapy hinge on setting accurate expectations, delivering high-quality education, and personalizing dietary recommendations to meet individual needs
The gene expression omnibus database
Eli Lilly launched Foundayo, the first oral GLP-1 for weight loss that can be taken any time of day without food or water restrictions
These food-based GLP-1 strategies may support microbial fermentation, satiety signaling, and metabolic balance as part of a broader diet-first approach